A carregar...
Biomarkers in pancreatic adenocarcinoma: current perspectives
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival rate of 7.7%. Most patients are diagnosed at an advanced stage not amenable to potentially curative resection. A substantial portion of this review is dedicated to reviewing the current literature on carbohydrate an...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5158171/ https://ncbi.nlm.nih.gov/pubmed/28003762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S100510 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|